Live Breaking News & Updates on Cyclopharm

Stay informed with the latest breaking news from Cyclopharm on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cyclopharm and stay connected to the pulse of your community

Cyclopharm Limited (ASX:CYC) Insider David Heaney Acquires 10,000 Shares

Cyclopharm Limited (ASX:CYC – Get Free Report) insider David Heaney acquired 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average cost of A$2.04 ($1.30) per share, for a total transaction of A$20,400.00 ($12,993.63). Cyclopharm Stock Performance The company has a current ratio of 3.90, […]

Canada , David-heaney , Asia-pacific , Cyclopharm-company-profile , Cyclopharm-limited , Get-free-report , Molecular-imaging , Cyclopharm-daily , Cyclopharm , Asx-cyc , Cyc , Medical

David Heaney Purchases 10,000 Shares of Cyclopharm Limited (ASX:CYC) Stock

Cyclopharm Limited (ASX:CYC – Get Rating) insider David Heaney purchased 10,000 shares of the business’s stock in a transaction on Tuesday, June 14th. The shares were bought at an average price of A$1.15 ($0.80) per share, for a total transaction of A$11,450.00 ($7,951.39). David Heaney also recently made the following trade(s): On Thursday, May 19th, […]

Canada , Asia-pacific , David-heaney , Cyclopharm-limited , Get-rating , Molecular-imaging , Cyclopharm , Asx-cyc , Cyc , Medical , Insider-trading , Nsider-trades